查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589793

腎上腺素自動注射器市場：按劑量、最終用戶分類 - 2025-2030 年全球預測

Epinephrine Auto-Injector Market by Dosage (0.3 Mg Epinephrine Autoinjector, 0.5 Mg Epinephrine Autoinjector, Mg Epinephrine Autoinjector), End-User (Clinics, Hospital, Individual) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

腎上腺素自動注射器市場2023年估值為3.5101億美元，預計到2024年將達到3.8483億美元，複合年成長率為9.73%，到2030年將達到6.724億美元。

腎上腺素自動注射器市場包括專門設計用於在通常由食物、昆蟲叮咬和其他過敏原引起的危及生命的過敏反應（稱為過敏反應）中快速注射腎上腺素的設備。這些自動注射器的需求源自於準確、快速地注射腎上腺素的能力。這種腎上腺素對於對抗嚴重的過敏反應至關重要，並列出了在獲得醫療幫助之前的重要干預措施。該市場具有廣泛的應用範圍，包括醫療設施、教育機構和家庭環境，最終用戶包括被診斷患有過敏症的個人和醫療保健專業人員。該市場的成長主要受到食物過敏發生率上升、政府法規要求學校儲備這些設備以及消費者意識不斷提高的影響。此外，在開發使用者友善設計、創新培訓技術、提高成本效益以及增加新興經濟體市場進入也存在潛在機會。限制市場成長的挑戰包括產品成本高、監管障礙以及由於分銷效率低下而在某些地區獲得注射器的機會有限。此外，召回和技術故障可能會影響消費者的信心和採用率。專注於透過智慧醫療設備增強注射器可靠性、便攜性和數位連接性的創新可以為該市場的重大進步鋪平道路。對腎上腺素替代輸送機制和配方的研究可能會開闢進一步新的成長途徑。永續性和環保的處置方法也可以創造符合全球環境目標的新機會。儘管市場面臨挑戰，但在基本醫療需求和客戶對安全、有效和易於獲得的緊急醫療解決方案的持續需求的推動下，腎上腺素自動注射器市場的本質仍然具有彈性。

主要市場統計
基準年[2023] 35101萬美元
預測年份 [2024] 38483萬美元
預測年份 [2030] 6.724 億美元
複合年成長率（%） 9.73%

市場動態：揭示快速發展的腎上腺素自動注射器市場的關鍵市場洞察

腎上腺素自動注射器市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人們對過敏的認知不斷增強
    • 研究與開發的技術發展
    • 對自動注射器取代標準注射器等傳統設備的巨大需求
  • 市場限制因素
    • 腎上腺素自動注射器高成本
  • 市場機會
    • 對易於使用的一次性注射器的需求
    • 更多採用過敏反應的自我管理
  • 市場問題
    • 嚴格的政府法規

波特五力：駕馭腎上腺素自動注射器市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解腎上腺素自動注射器市場的外部影響

外部宏觀環境因素在塑造腎上腺素自動注射器市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解腎上腺素自動注射器市場的競爭格局

腎上腺素自動注射器市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣：腎上腺素自動注射器市場供應商的績效評估

FPNV 定位矩陣是評估腎上腺素自動注射器市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製腎上腺素自動注射器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，腎上腺素自動注射器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

它也回答重要問題，幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們對過敏的認知不斷增強
      • 研究和開發活動中的技術開發
      • 作為標準注射器等傳統設備的替代品，自動注射器的需求量大
    • 抑制因素
      • 腎上腺素自動注射器高成本
    • 機會
      • 一次性藥物注射器易用性的需求
      • 更多採用過敏反應的自我管理
    • 任務
      • 嚴格的政府法規
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 腎上腺素自動注射器市場：按劑量

  • 介紹
  • 0.3mg 腎上腺素自動注射器
  • 0.5 毫克腎上腺素自動注射器
  • 鎂腎上腺素自動注射器

第 7 章 腎上腺素自動注射器市場：依最終使用者分類

  • 介紹
  • 診所
  • 醫院
  • 個人

第8章美洲腎上腺素自動注射器市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區腎上腺素自動注射器市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲腎上腺素自動注射器市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ALK-Abello A/S
  • Amgen Inc.
  • Amneal Pharmaceuticals Inc.
  • Antares Pharma Inc. by Halozyme Therapeutics, Inc.
  • Bausch Health Companies, Inc.
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Kaleo, Inc.
  • Lincoln Medical Centre Ltd.
  • Merck KGaA
  • Pfizer, Inc.
  • Sanofi SA
  • Shionogi Pharma, Inc.
  • Teva Pharmaceuticals Ltd.
  • Viatris
Product Code: MRR-4348D129FAC8

The Epinephrine Auto-Injector Market was valued at USD 351.01 million in 2023, expected to reach USD 384.83 million in 2024, and is projected to grow at a CAGR of 9.73%, to USD 672.40 million by 2030.

The epinephrine auto-injector market encompasses devices designed for the swift delivery of epinephrine, particularly in life-threatening allergic reactions known as anaphylaxis, often triggered by foods, insect stings, or other allergens. The necessity of these auto-injectors arises from their ability to deliver a precise and rapid dose of epinephrine, which is vital in counteracting severe allergic responses, offering critical intervention until medical assistance is available. The market's application spans across healthcare facilities, educational institutions, and domestic environments, with end-users including individuals with diagnosed allergies and healthcare providers. The growth of this market is primarily influenced by the rising incidence of food allergies and increasing government regulations mandating schools to have these devices on hand, alongside heightened consumer awareness. Furthermore, potential opportunities can be seen in the development of user-friendly designs, innovative training technologies, and improved cost-effectiveness, coupled with expanding market access in emerging economies. Challenges restraining market growth include high product costs, regulatory hurdles, and limited access to injectors in some regions due to distribution inefficiencies. Additionally, recalls and technical malfunctions can impact consumer trust and adoption rates. Innovations focusing on enhancing injector reliability, portability, and digital connectivity through smart medical devices can pave the way for significant advancements within the market. Exploring research into alternative delivery mechanisms or formulations of epinephrine can further present new growth avenues. Sustainability and eco-friendly disposal options might also create new opportunities in line with global environmental goals. Despite market challenges, the nature of the epinephrine auto-injector market remains resilient, driven by essential healthcare needs and persistently growing customer demand for safe, effective, and readily accessible emergency medical solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 351.01 million
Estimated Year [2024] USD 384.83 million
Forecast Year [2030] USD 672.40 million
CAGR (%) 9.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Epinephrine Auto-Injector Market

The Epinephrine Auto-Injector Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing awareness about allergies
    • Technological developments in research & development activities
    • High demand for autoinjectors instead of conventional devices such as standard syringes
  • Market Restraints
    • High cost of epinephrine auto injector
  • Market Opportunities
    • Demand for easy usability of disposable drug injectors
    • Increasing adoption self-management of anaphylaxis
  • Market Challenges
    • Stringent regulations imposed by the government

Porter's Five Forces: A Strategic Tool for Navigating the Epinephrine Auto-Injector Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Epinephrine Auto-Injector Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Epinephrine Auto-Injector Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Epinephrine Auto-Injector Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Epinephrine Auto-Injector Market

A detailed market share analysis in the Epinephrine Auto-Injector Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Epinephrine Auto-Injector Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Epinephrine Auto-Injector Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Epinephrine Auto-Injector Market

A strategic analysis of the Epinephrine Auto-Injector Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Epinephrine Auto-Injector Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Amgen Inc., Amneal Pharmaceuticals Inc., Antares Pharma Inc. by Halozyme Therapeutics, Inc., Bausch Health Companies, Inc., Becton, Dickinson and Company, Eli Lilly and Company, Kaleo, Inc., Lincoln Medical Centre Ltd., Merck KGaA, Pfizer, Inc., Sanofi SA, Shionogi Pharma, Inc., Teva Pharmaceuticals Ltd., and Viatris.

Market Segmentation & Coverage

This research report categorizes the Epinephrine Auto-Injector Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Dosage, market is studied across 0.3 Mg Epinephrine Autoinjector, 0.5 Mg Epinephrine Autoinjector, and Mg Epinephrine Autoinjector.
  • Based on End-User, market is studied across Clinics, Hospital, and Individual.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness about allergies
      • 5.1.1.2. Technological developments in research & development activities
      • 5.1.1.3. High demand for autoinjectors instead of conventional devices such as standard syringes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of epinephrine auto injector
    • 5.1.3. Opportunities
      • 5.1.3.1. Demand for easy usability of disposable drug injectors
      • 5.1.3.2. Increasing adoption self-management of anaphylaxis
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations imposed by the government
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Epinephrine Auto-Injector Market, by Dosage

  • 6.1. Introduction
  • 6.2. 0.3 Mg Epinephrine Autoinjector
  • 6.3. 0.5 Mg Epinephrine Autoinjector
  • 6.4. Mg Epinephrine Autoinjector

7. Epinephrine Auto-Injector Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospital
  • 7.4. Individual

8. Americas Epinephrine Auto-Injector Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Epinephrine Auto-Injector Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Epinephrine Auto-Injector Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ALK-Abello A/S
  • 2. Amgen Inc.
  • 3. Amneal Pharmaceuticals Inc.
  • 4. Antares Pharma Inc. by Halozyme Therapeutics, Inc.
  • 5. Bausch Health Companies, Inc.
  • 6. Becton, Dickinson and Company
  • 7. Eli Lilly and Company
  • 8. Kaleo, Inc.
  • 9. Lincoln Medical Centre Ltd.
  • 10. Merck KGaA
  • 11. Pfizer, Inc.
  • 12. Sanofi SA
  • 13. Shionogi Pharma, Inc.
  • 14. Teva Pharmaceuticals Ltd.
  • 15. Viatris

LIST OF FIGURES

  • FIGURE 1. EPINEPHRINE AUTO-INJECTOR MARKET RESEARCH PROCESS
  • FIGURE 2. EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EPINEPHRINE AUTO-INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. EPINEPHRINE AUTO-INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPINEPHRINE AUTO-INJECTOR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPINEPHRINE AUTO-INJECTOR MARKET DYNAMICS
  • TABLE 7. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EPINEPHRINE AUTO-INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. EPINEPHRINE AUTO-INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023